Doctor profile · Federal record

Dr. Katherine Sanchez, MD

Medical Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Internal Medicine Physician · Hematology & Oncology Physician · Albuquerque, NM

  • NPI 1558740647
  • Accepts Medicare
  • MIPS 85.3 / 100 · 2023
  • 11 yrs in practice
  • Licensed in 3 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
4901 Lang Ave Ne
Albuquerque, NM 871094397
(505) 842-8171
Additional location
5050 Ne Hoyt St, Suite 540
Portland, OR 972132985
(503) 215-6600
Additional location
400 Ne Mother Joseph Pl
Vancouver, WA 986643200
(360) 514-2000

Credentials & registration

NPPES · NUCC
NPI registered
May 2015 — 11 yrs on file
Profile last updated
October 1, 2024
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (3)
New Mexico #MD2022-0212 · Washington #MD60876147 · Oregon #MD179481

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1558740647. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
38,410
Distinct HCPCS
10
Medicare allowed
$712,731
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 14,250 17 $1
J9271 Injection, pembrolizumab, 1 mg 8,400 15 $54
J9263 Injection, oxaliplatin, 0.5 mg 8,000 11 $0
J0897 Injection, denosumab, 1 mg 2,220 21 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,469 50 $0
J2469 Injection, palonosetron hcl, 25 mcg 1,060 42 $1
99215 Established patient office or other outpatient visit, 40-54 minutes 464 246 $170
J0640 Injection, leucovorin calcium, per 50 mg 420 13 $4
J9190 Injection, fluorouracil, 500 mg 272 14 $2
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 224 69 $27

In context: peer comparison

Among 3 peers in this city , average services per provider: 1,158. This provider delivers 33× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$5,427
Transactions
23
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 6 $1,920.50
Lilly USA, LLC 5 $1,613.56
Eli Lilly and Company 1 $1,500.00
Gilead Sciences, Inc. 3 $260.43
Eisai Inc. 1 $23.33
Ipsen Biopharmaceuticals, Inc 1 $19.43
Celgene Corporation 1 $19.30
Regeneron Healthcare Solutions, Inc. 1 $17.02
PharmaEssentia USA Corporation 1 $15.30
Takeda Pharmaceuticals U.S.A., Inc. 1 $14.13
SOBI, INC 1 $13.36
Merck Sharp & Dohme LLC 1 $10.85

By nature of payment

Consulting Fee
$4,665
Food and Beverage
$734
Education
$28

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
390
Patients
95
Total drug cost
$842,286
Drug Type Claims Patients Total cost
Letrozole Generic 166 62 $6,167
Tamoxifen Citrate Generic 25 0 $1,170
Exemestane Generic 21 0 $5,912
Anastrozole Generic 20 11 $630
Kisqali (Ribociclib Succinate) Brand 18 0 $259,881
Ondansetron Odt (Ondansetron) Brand 18 11 $737
Oxycodone Hcl Generic 16 0 $381
Gabapentin Generic 15 0 $100
Lidocaine-Prilocaine (Lidocaine/Prilocaine) Brand 15 11 $259
Xarelto (Rivaroxaban) Brand 15 0 $14,807

Frequently asked questions

Auto-generated from federal data
What is Dr. Katherine Sanchez's medical specialty?
Dr. Katherine Sanchez practices Medical Oncology Physician in Albuquerque, NM.
Where does Dr. Katherine Sanchez practice?
Dr. Katherine Sanchez practices at 4901 Lang Ave Ne, Albuquerque, NM 871094397. Office phone: 5058428171.
What is Dr. Katherine Sanchez's NPI?
Dr. Katherine Sanchez's National Provider Identifier (NPI) is 1558740647, issued by NPPES.
Does Dr. Katherine Sanchez accept Medicare assignment?
Yes. Dr. Katherine Sanchez accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Katherine Sanchez commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, oxaliplatin, 0.5 mg (HCPCS J9263). Source: CMS Medicare Physician & Other Practitioners file.